Revenue (Tables)

6 Months Ended

Jun. 30, 2025

Revenue from Contract with Customer [Abstract]

Revenue by product for the periods indicated were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands)	2025		2024		2025		2024
CHEMOSAT	$	1,656	$	1,196	$	3,417	$	2,327
HEPZATO KIT	22,500		6,570		40,523		8,578
Total revenue	$	24,156	$	7,766	$	43,940	$	10,905

Schedule of Revenue and Accounts Receivable Concentrations

The Company’s total percentage of revenue and accounts receivable balances were comprised of the following concentrations from its largest customers, based on whose revenue and/or accounts receivable concentration is greater than 10% of total revenue or total accounts receivable in the periods disclosed below:


For the six months ended and as of June 30, 2025	% of Revenue		% of Accounts Receivable
Customer 1	13.1	%	11.8	%
Customer 2	12.3	%	14.2	%
Customer 3	11.0	%	5.9	%


For the six months ended and as of June 30, 2024	% of Revenue		% of Accounts Receivable
Customer 1	51.7	%	34.3	%
Customer 2	23.5	%	29.4	%
Customer 3	11.7	%	4.9	%